Expression of genes encoding cytokines and corticotropin releasing factor are altered by citalopram in the hypothalamus of post-stroke depression rats

Neuroendocrinology Letters

Volumn 34, Issue 8, 2013, Pages 773-779

  Wang, Shan Shan ^a   Wang, Ya Guang ^b   Chen, Hai Ying ^a   Wu, Zhi Ping ^a   Xie, Heng Ge ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Corticotropin releasing factor; Cytokines; Interleukin 1 beta; Post stroke depression; Tumor necrosis factor alpha

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; INTERLEUKIN 1BETA; MESSENGER RNA; SEROTONIN UPTAKE INHIBITOR; SUCROSE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; GENE EXPRESSION; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOCOMOTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN FIELD TEST; POSTSTROKE DEPRESSION; RAT; SUCROSE PREFERENCE TEST;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; CORTICOTROPIN-RELEASING HORMONE; CYTOKINES; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; MALE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; STROKE;

EID: 84895832332     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bah TM, Benderdour M, Kaloustian S, Karam R, Rousseau G, Godbout R (2011). Escitalopram reduces circulating pro-inflammatory cytokines and improves depressive behavior without affecting sleep in a rat model of post-cardiac infarct depression. Behav Brain Res 225:243-251.
2. Bao AM, Meynen G, Swaab DF (2008). The stress system in depression and neurodegeneration: Focus on the human hypothalamus. Brain Res Rev 57:531-553. (Pubitemid 351381758)
3. Bernardini R, Kamilaris TC, Calogero AE, Johnson EO, Gomez MT, Gold PW, et al (1990). Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology 126: 2876-2881. (Pubitemid 20216538)
4. Dantzer R (2001). Cytokine-induced sickness behavior: Where do we stand? Brain Behav Immun 15:7-24.
5. Ellis P (2004). Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust N Z J Psychiatry 38:389-407.
6. Hill JK, Gunion-Rinker L, Kulhanek D, Lessov N, Kim S, Clark WM, et al (1999). Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain Res 820:45-54. (Pubitemid 29225477)
7. Hwang J, Zheng LT, Ock J, Lee MG, Kim SH, Lee HW, et al (2008). Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology 55:826-834.
8. Jensen JB, Jessop DS, Harbuz MS, Mork A, Sanchez C, Mikkelsen JD (1999). Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats. J Neuroendocrinol 11: 465-471. (Pubitemid 29243770)
9. Kageyama K, Kagaya S, Takayasu S, Hanada K, lwasaki Y, Suda T (2010). Cytokines induce NF-kappaB, Nurrl and corticotropinreleasing factor gene transcription in hypothalamic 4B cells. Neuroimmunomodulation 17:305-313.
10. Kakucska I, Qi Y, Clark BD, Lechan RM (1993). Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology 133:815-821. (Pubitemid 23238897)
11. Kronenberg G, Balkaya M, Prinz V, Gertz K, Ji S, Kirste I, et al (2012). Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression. Biol Psychiatry 72:273-281.
12. Longa EZ, Weinstein PR, Carlson S, Cummins R (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91. (Pubitemid 19040218)
13. Martensson U, Nassberger L (1993). Influence of antidepressants on mitogen stimulation of human lymphocytes. Toxicol In Vitro 7:241-245.
14. Papp M, Nalepa I, Antkiewicz-Michaluk L, Sanchez C (2002). Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model. Pharmacol Biochem Behav 72:465-474. (Pubitemid 34251360)
15. Salazar-Colocho P, Del Rio J, Frechilla D (2008). Neuroprotective effects of serotonin 5-HT1A receptor activation against ischemic cell damage in gerbil hippocampus: Involvement of NMDA receptor NR1 subunit and BDNF. Brain Res 1199:159-166.
16. Spalletta G, Bossu P, Ciaramella A, Bria P, Caltagirone C, Robinson RG (2006). The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry 11:984-991. (Pubitemid 44631641)
17. Su JA, Chou SY, Tsai CS, Hung TH (2012). Cytokine changes in the pathophysiology of poststroke depression. Gen Hosp Psychiatry 34:35-39.
18. Turnbull AV, Rivier CL (1999). Regulation of the hypothalamicpituitary- adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79:1-71. (Pubitemid 29056948)
19. Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA, Walker FR (2012). A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun 26:469-479.
20. Wang S, Yuan Y, Xia W, Li F, Huang Y, Zhou Y, et al (2012). Neuronal apoptosis and synaptic density in the dentate gyrus of ischemic rats' response to chronic mild stress and the effects of Notch signaling. PLoS One 7: e42828. doi: 10.1371/journal.pone.0042828.
21. Wang SH, Zhang ZJ, Guo YJ,Teng GJ, Chen BA (2008). Hippocampal neurogenesis and behavioural studies on adult Ischemic rat response to chronic mild stress. Behav Brain Res 189:9-16.
22. Wang SH, Zhang ZJ, Guo YJ, Zhou H, Teng GJ, Chen BA (2009). Anhedonia and activity deficits in rats: Impact of post-stroke depression. J Psychopharmacol 23:295-304.
23. Wang SS, Yan XB, Hofman MA, Swaab DF, Zhou JN (2010). Increased expression level of corticotropin-releasing hormone in the amygdala and In the hypothalamus in rats exposed to chronic unpredictable mild stress. Neurosci Bull 26:297-303.
24. Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P (2011). Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci U S A 108:9262-9267.
25. Willner P (1997). Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology (Berl) 134:319-329.
26. Willner P, Muscat R, Papp M (1992). Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16:525-534.
27. Willner P,Towell A, Sampson D, Sophokleous S, Muscat R (1987). Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93:358-364. (Pubitemid 17160661)
28. Xing B, Bachstetter AD, Van Eldik LJ (2011). Microglial p38alpha MAPK Is critical for LPS-induced neuron degeneration through a mechanism involving TNFalpha. Mol Neurodegener 6: 84, doi: 10.1186/1750-1326-6-84.
29. Ying G, Karlsson H, Depierre JW, Nassberger L (2002). Tricyclic antidepressants prevent the differentiation of monocytes into macrophage-like cells in vitro. Cell Biol Toxicol 18:425-437. (Pubitemid 35396705)
30. Zaremba J, Losy J (2001). Early TNF-alpha levels correlate with ischaemic stroke severity. Acta Neurol Scand 104:288-295. (Pubitemid 32977149)
31. Wang-Rischer YL (2008). Manual of stroke models In Rats. CRC Press: pp 108-125.